1-7 of 7
Bridget A. Knight
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Routine Islet Autoantibody Testing in Clinically Diagnosed Adult-Onset Type 1 Diabetes Can Help Identify Misclassification and the Possibility of Successful Insulin Cessation

Free
Russell J. Eason, Nicholas J. Thomas, Anita V. Hill, Bridget A. Knight, Alice Carr, Andrew T. Hattersley, Timothy J. McDonald, Beverley M. Shields, Angus G. Jones, for the StartRight Study Group, Godwin Simon, Angelo Ramos, Andrea Norris, Kai Tan, Parth Narendran, Shenaz Ramtoola, Amar Ali, Moulinath Banerjee, Augustin Brooks, Ali Chakera, Andrew Johnson, Danijela Tatovic, Chitrabhanu Ballav, Colin Dayan, Sunil Nair, Frances Game, Angus Jones, Susan Beames, Gerry Rayman, Marie Snell, Susie Butler, Sarah Beck, Janet Beecham, John Wilding, Sam Rice, Mimi Chen, Athinyaa Thiraviaraj, Siva Sivappriyan, Basil Issa, Asif Humayun, Rebecca Hinch, Leena Krishnan, Khin Swe Myint, Charles Fox, Jennifer Prouten, Mike Sampson, Peter Mansell, Carolyn Chee, Katharine Owen, Ioannis Dimitropoulis, Michael Cummings, Foteini Kavourra, Adrian Heald, Simon Heller, Sarbpreet Sihota, Vakkat Muraleedharan, Tara Watson, Hermione Price, Roger Whittaker, Sarah Orme, Ben Field, Stephen Bain, Beas Battacharya, Lesley Haxton, Suzannah Pegler, Catherine Thompson, Rob Andrew, Jamie Smith, Duncan Browne, Steve Creely, Rahul Yadav, Rakhi Kakad, Ken Laji, Mohit Kumar, Alirezi Mohammadi, James Young, Seshadri Pramodh, Vijay Jayagopal
Journal: Diabetes Care
Diabetes Care 2022;45(12):2844–2851
https://doi.org/10.2337/dc22-0623
Published: 07 October 2022
View articletitled, Routine Islet Autoantibody Testing in Clinically Diagnosed Adult-Onset Type 1 Diabetes Can Help Identify Misclassification and the Possibility of Successful Insulin Cessation
Open the PDF for Routine Islet Autoantibody Testing in Clinically Diagnosed Adult-Onset Type 1 Diabetes Can Help Identify Misclassification and the Possibility of Successful Insulin Cessation in another window
Journal Articles

Cognitive, Neurological, and Behavioral Features in Adults With KCNJ11 Neonatal Diabetes

Free
Pamela Bowman, Jacob Day, Lorna Torrens, Maggie H. Shepherd, Bridget A. Knight, Tamsin J. Ford, Sarah E. Flanagan, Ali Chakera, Andrew T. Hattersley, Adam Zeman
Journal: Diabetes Care
Diabetes Care 2019;42(2):215–224
https://doi.org/10.2337/dc18-1060
Published: 30 October 2018
View articletitled, Cognitive, Neurological, and Behavioral Features in Adults With KCNJ11 Neonatal Diabetes
Open the PDF for Cognitive, Neurological, and Behavioral Features in Adults With KCNJ11 Neonatal Diabetes in another window
Includes: Supplementary data
Journal Articles

Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy

Free
John M. Dennis, Beverley M. Shields, Anita V. Hill, Bridget A. Knight, Timothy J. McDonald, Lauren R. Rodgers, Michael N. Weedon, William E. Henley, Naveed Sattar, Rury R. Holman, Ewan R. Pearson, Andrew T. Hattersley, Angus G. Jones
Journal: Diabetes Care
Diabetes Care 2018;41(4):705–712
https://doi.org/10.2337/dc17-1827
Published: 31 January 2018
View articletitled, Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy
Open the PDF for Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy in another window
Includes: Supplementary data
Journal Articles

Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes

Free
Angus G. Jones, Timothy J. McDonald, Beverley M. Shields, Anita V. Hill, Christopher J. Hyde, Bridget A. Knight, Andrew T. Hattersley
Journal: Diabetes Care
Diabetes Care 2016;39(2):250–257
https://doi.org/10.2337/dc15-0258
Published: 04 August 2015
View articletitled, Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes
Open the PDF for Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes

Open Access
Rachel E.J. Besser, MBBS, Johnny Ludvigsson, PHD, Angus G. Jones, MBBS, Timothy J. McDonald, MSC, Beverley M. Shields, PHD, Bridget A. Knight, PHD, Andrew T. Hattersley, DM
Journal: Diabetes Care
Diabetes Care 2011;34(3):607–609
https://doi.org/10.2337/dc10-2114
Published: 17 February 2011
View articletitled, Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes
Open the PDF for Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Urinary C-Peptide Creatinine Ratio Is a Practical Outpatient Tool for Identifying Hepatocyte Nuclear Factor 1-α/Hepatocyte Nuclear Factor 4-α Maturity-Onset Diabetes of the Young From Long-Duration Type 1 Diabetes

Open Access
Rachel E.J. Besser, MBBS, Maggie H. Shepherd, PHD, Timothy J. McDonald, MSC, Beverley M. Shields, PHD, Bridget A. Knight, PHD, Sian Ellard, PHD, Andrew T. Hattersley, DM
Journal: Diabetes Care
Diabetes Care 2011;34(2):286–291
https://doi.org/10.2337/dc10-1293
Published: 20 January 2011
View articletitled, Urinary C-Peptide Creatinine Ratio Is a Practical Outpatient Tool for Identifying Hepatocyte Nuclear Factor 1-α/Hepatocyte Nuclear Factor 4-α Maturity-Onset Diabetes of the Young From Long-Duration Type 1 Diabetes
Open the PDF for Urinary C-Peptide Creatinine Ratio Is a Practical Outpatient Tool for Identifying Hepatocyte Nuclear Factor 1-α/Hepatocyte Nuclear Factor 4-α Maturity-Onset Diabetes of the Young From Long-Duration Type 1 Diabetes in another window
Includes: Supplementary data
Journal Articles

Mutations in the Glucokinase Gene of the Fetus Result in Reduced Placental Weight

Free
Beverley M. Shields, PHD, Gill Spyer, MD, MRCP, Annabelle S. Slingerland, MD, MPH, Bridget A. Knight, PHD, Sian Ellard, PHD, MRCPATH, Penelope M. Clark, PHD, FRCPATH, Sylvie Hauguel-de Mouzon, PHD, Andrew T. Hattersley, DM, FRCP
Journal: Diabetes Care
Diabetes Care 2008;31(4):753–757
https://doi.org/10.2337/dc07-1750
Published: 01 April 2008
View articletitled, Mutations in the Glucokinase Gene of the Fetus Result in Reduced Placental Weight
Open the PDF for Mutations in the Glucokinase Gene of the Fetus Result in Reduced Placental Weight in another window